Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...

The FINANCIAL — Elekta (EKTA-B.ST), Royal Philips and The Netherlands Cancer Institute, (NKI, Amsterdam, the Netherlands) on April 17 announced the installation of a high-field (1.5 Tesla) MR-guided ...

HOUSTON--(BUSINESS WIRE)--Regulatory News: The University of Texas MD Anderson Cancer Center has signed a deal with Elekta (EKTA-B.ST) to acquire Elekta Infinity ...

GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...

Elekta, a company based in Sweden, is one of the world's leaders in developing some of the most cutting-edge cancer treatment technologies — and Mary Bird Perkins Cancer Center has worked with them ...

Medical Linear Accelerators Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done ...

In order to deliver Adaptive Radiation Therapy (ART) for cancer, Elekta, a global leader in precision radiation therapy, will launch an advanced AI-enabled CT-Linac (linear accelerator) by the name ...

ATLANTA — With much pomp and circumstance, Elekta (Stockholm, Sweden) unveiled its Versa HD, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of ...

* ORDER IS IN ADDITION TO SIX VERSA HD LINACS PREVIOUSLY BOOKED IN Q2 OF ELEKTA'S FISCAL YEAR 2019/20 * IN THIS FISCAL YEAR, GACEQ HAS AWARDED ELEKTA A TOTAL ORDER VALUE OF APPROXIMATELY CAD 56 ...